Character building: US FDA sets strict guidance on pharma tweets
Drug firms that tweet to promote pharmaceuticals will also need to detail their most serious risks under newly issued USFDA draft guidance.
Drug firms that tweet to promote pharmaceuticals will also need to detail their most serious risks under newly issued USFDA draft guidance.
Dispatches from the GPCM Conference, London, UK
Big pharma is moving towards strategic partnerships with CMOs, according to speakers at the Global Pharmaceutical Contract Manufacturing (GPCM) Conference, with the ideal number of partners being ten.
Drug raw materials suppliers have not recognised their potential value to biopharmaceutical customers according to Roche which has called for a transformation in the vendor relationship.
The US National Institutes of Health (NIH) has unveiled a policy that will balance testing on male and female animals and cells in preclinical tests.
Dispatches from DIA
A year after CRO Parexel saw what its CEO called “hyper growth,” the Massachusetts-based company is seeing revenue gains return to relatively normal levels.